CYP2C9 Target & Gene Products-cDNA ORF clones/siRNA/antibody/protein

Explore CYP2C9 gene products and cross-species research data at TarMart platform. Discover comprehensive biological information, expression tools, and therapeutic insights for Homo sapiens (human), Cynomolgus monkeys, rodents (mouse/rat), canines, felines, bovines, and equines. Your premier destination for multi-species gene research solutions
Target sublocation: Transmembrane Protein.
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008]

Target ID GM-T19244
Target Name CYP2C9
Gene Group ldentifer
(Target Gene ID in Homo species)
1559
Gene ID 1559 (Homo sapiens)
Target Alternative Names (R)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase,(S)-limonene 7-monooxygenase,CPC9,CYP2C,CYP2C10,CYP2C9,CYPIIC9,Cholesterol 25-hydroxylase,Cytochrome P-450MP,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,P450-2C9,P450IIC9,S-mephenytoin 4-hydroxylase
Uniprot Accession P11712
Protein Sub-location Transmembrane Protein
Category Therapeutics Target
Disease cancer
Disease from KEGG Metabolic pathways, Serotonergic synapse, Chemical carcinogenesis - DNA adducts, Lipid and atherosclerosis, Arachidonic acid metabolism, Linoleic acid metabolism, Retinol metabolism, Drug metabolism - cytochrome P450
Gene Ensembl ENSG00000138109
Target Classification Tumor-associated antigen (TAA)


Pre-made viral vector of CYP2C9 cDNA Clones/ORF Plasmid

Cat No.Product NameNMIDGeneIDSpeciesTypeMarkerFusion TagPromoterDetail
pGMAP000534Human CYP2C9/CPC9/CYP2C Adenovirus plasmidBC1250541559HumanAdenovirus plasmidGFP3xflag (C-Terminal)EF1Detail
pGMAP000551Human CYP2C9/CPC9/CYP2C Adenovirus plasmidBC1250541559HumanAdenovirus plasmidGFP3xflag (C-Terminal)EF1Detail
vGMAP000534Human CYP2C9/CPC9/CYP2C Adenovirus particleBC1250541559HumanAdenovirus particleGFP3xflag (C-Terminal)EF1Detail
vGMAP000551Human CYP2C9/CPC9/CYP2C Adenovirus particleBC1250541559HumanAdenovirus particleGFP3xflag (C-Terminal)EF1Detail


CYP2C9 siRNA/miRNA/oligo for RNA interfence (RNAi)

Cat No.Product NameGeneIDSpeciesGradeDetail
pGMoligo1559Pre-made Human CYP2C9/CPC9/CYP2C siRNA oligo Duplex1559HumanIn-vitro grade; in-vivo gradeDetail


CYP2C9 antibody/GMab

Cat No.SpeciesAntibody NameFormatClassified by tagDetail
GM-Tg-hg-T19244-AbHumanAnti-Human CYP2C9 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail


CYP2C9 VLP (virus-like particle)/protein

Cat No.SpeciesAntigen NameExpression PlatformDetail
GM-Tg-hg-T19244-AgHumanHuman CYP2C9 VLP (virus-like particle)HEK293Products Developing